Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma-Reference-Cited by-同舟云学术

Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma

Published:2020-08-16 Issue:3 Volume:72 Page:965-981
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Job Sylvie¹,Rapoud Delphine²³,Dos Santos Alexandre²³,Gonzalez Patrick²³,Desterke Christophe³,Pascal Gérard²³,Elarouci Nabila¹,Ayadi Mira¹,Adam René²³,Azoulay Daniel²³,Castaing Denis²³,Vibert Eric²³,Cherqui Daniel²³,Samuel Didier²³,Sa Cuhna Antonio²³,Marchio Agnès⁴,Pineau Pascal⁴^ORCID,Guettier Catherine²³⁵,Reyniès Aurélien¹,Faivre Jamila²³⁶

Affiliation:

1. Programme Cartes d’Identité des Tumeurs Ligue Nationale Contre le Cancer Paris France

2. Hepatobiliary Centre INSERM, U1193, Paul‐Brousse University Hospital Villejuif France

3. Faculté de Médecine du Kremlin Bicetre University Paris‐Sud, Université Paris‐Saclay Le Kremlin‐Bicêtre France

4. Unité ‘Organisation Nucléaire et Oncogenèse’, INSERM U993 Institut Pasteur Paris France

5. Pathology Department Assistance Publique‐Hôpitaux de Paris (AP‐HP)Kremlin‐Bicêtre Hospital Le Kremlin‐Bicêtre France

6. Pôle de Biologie Médicale Laboratoire d’Onco‐Hématologie Paul‐Brousse University Hospital Assistance Publique‐Hôpitaux de Paris (AP‐HP) Villejuif France

Funder

FP7 Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31092

Reference46 articles.

1. Intrahepatic Cholangiocarcinoma

2. Cholangiocarcinoma — evolving concepts and therapeutic strategies

3. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer